Crystal Research Associates Discusses HIV Vaccine and H1N1 Flu Vaccines

Strategic Insights -

Crystal Research Associates' chief executive officer and cofounder, Jeffrey Kraws, was recently interviewed by Bloomberg Television, discussing the progress of a potential HIV vaccine in clinical testing and the challenges facing the development of H1N1 flu vaccines. Mr. Kraws highlighted recent advancements in vaccine technologies at biotechnology companies such as CEL-SCI Corporation, Generex Biotechnology Corporation, and Unilife Medical Solutions Limited. These advancements could supplement the research conducted by larger pharmaceutical companies.

Key Takeaways:

  • Crystal Research Associates' Jeffrey Kraws discussed the progress of a potential HIV vaccine in clinical testing on Bloomberg Television.
  • Kraws highlighted the advancements in vaccine technologies at biotechnology companies CEL-SCI Corporation, Generex Biotechnology Corporation, and Unilife Medical Solutions Limited.
  • These advancements could help supplement the research and development conducted by larger pharmaceutical companies.
  • The interview showcased the importance of vaccine technologies in addressing global health challenges.
  • Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto.
  • The company's unique product, the Executive Informational Overview (EIO), presents detailed reports on companies' product/technology/service offerings, market size(s), and growth strategy.

Statistics:

  • The HIV vaccine in clinical testing is a potential solution to addressing the global health challenge of HIV/AIDS.
  • The H1N1 flu vaccines are currently facing challenges in their development process.
  • CEL-SCI Corporation has been working on developing vaccine technologies for various diseases, including cancer and infectious diseases.
  • Generex Biotechnology Corporation has been developing oral insulin for the treatment of type 1 diabetes and other diseases.
  • Unilife Medical Solutions Limited has been developing needle-free injection systems for various applications.

Sources:

  • Bloomberg Television
  • COMTEX
  • BAYSTREET NEWSWIRE
  • Surface SmarTrend(R) Alert
  • SmarTrend Bulletin